Rising Costs, Slowing Premiums: Why AM Best Predicts a Tougher 2026 for the P/C Insurance Market

Insurance financial analysis

After a relatively strong 2025 for the property/casualty insurance sector, AM Best is signaling a shift. According to new analysis reported by Insurance Journal, the industry may be facing a more challenging 2026 driven by slowing premium growth, inflationary pressure, and rising claims costs.

Premium Growth Slows as Rates Plateau

The momentum seen in 2025—supported by strong investment income and previous rate hikes—is starting to cool. AM Best’s latest industry report forecasts slowing net premium growth across many lines in 2026. This softening trend is expected to push the industry’s combined ratio up by 1.9 points to 96.9.

From cyber to D&O to commercial property, renewal pricing softened throughout 2025—and the trend appears likely to continue. Even workers’ compensation, traditionally a stable performer, saw its premium growth moderate last year.

Inflation Hits Claims Costs Hard

Jacqalene Lentz, Senior Director at AM Best, notes that rising prices for construction materials, auto parts, and commercial repair costs are pushing loss ratios higher. These macroeconomic pressures are cutting into the cushion insurers regained in 2025.

Even personal lines—which benefited from rate approvals and tech‑driven underwriting improvements—may feel pressure again in 2026. Higher auto fatality rates and increasing repair costs remain persistent challenges.

Commercial Lines Feel the Strain

Commercial lines are projected to reach a combined ratio of 96.3 in 2026—slightly worse than 2025’s 95.8. Auto, medical professional liability, and products liability each recorded combined ratios over 100 in 2025, indicating underwriting losses and ongoing stress.

Reserves: A Persistent Risk

AM Best’s re‑estimation of ultimate reserves revealed a $9 billion deficiency for year‑end 2024. While improved from earlier projections, reserve adequacy remains a major concern—and one of the clearest indicators of long‑term company solvency.

E&S Market Continues to Shine

As admitted carriers tightened underwriting or stepped away from volatile classes such as property and high‑hazard liability, the excess & surplus (E&S) market absorbed the overflow. AM Best calls this shift one of the defining forces of 2025—a trend expected to influence 2026 as well.

What This Means for Insurance Professionals

Whether you’re licensed or exploring a path into the industry, these shifts highlight the importance of staying skilled, informed, and adaptable. A year of flatter rate changes and rising claims severity means professionals will need sharper analysis, stronger risk‑evaluation skills, and a deep understanding of evolving market pressures.

If you’re considering entering or advancing within the insurance field, Cameron Academy provides flexible, career‑focused licensing programs designed to help professionals stay ahead of market changes and elevate their expertise.

To dive deeper into the original reporting, visit the full article on Insurance Journal.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The Remote Work Revolution: Redefining Real Estate

Imagine a morning where the commute is just a few steps from your bedroom to your home office. This is the reality for many in today's post-pandemic world, where remote work has become a staple of the modern workforce.

By |December 2, 2024|Categories: Article, Real Estate, Remote Work|Tags: , |0 Comments

CRISPR: The Future of Gene Editing and Its Clinical Implications

CRISPR technology has become the frontrunner in genome editing, surpassing earlier methods like zinc finger nucleases and transcription activator-like effector nucleases. The recent FDA approval of the CRISPR-Cas9 drug, exa-cel, marks a significant milestone particularly for treating sickle cell disease and transfusion-dependent beta thalassemia.

By |December 1, 2024|Categories: Article, Biotechnology, Medicine|Tags: , |0 Comments

AI Revolution in Oncology: Transformative Potential or Overhyped?

In recent years, artificial intelligence has emerged as a revolutionary tool in the field of oncology. AI's integration into healthcare transcends buzzwords, transforming cancer diagnosis, treatment personalization, and drug discovery.

AI in Radiology: A Double-Edged Sword

The rapid advancements in artificial intelligence (AI) are transforming the landscape of radiology, promising to enhance diagnostic accuracy and support personalized medicine. However, as this technology becomes more integral to medical imaging, it brings with it a host of ethical and societal considerations that cannot be ignored.

Humanity at the Crossroads: Ethical Implications of AI in Medicine

AI's promise in healthcare is undeniable, with its ability to uncover hidden disease patterns and predict illnesses. However, the reliance on historical data can exacerbate existing biases, particularly affecting marginalized communities such as the LGBTQIA+ and certain ethnic and racial groups.

The Future of Telemedicine: Challenges and Opportunities Beyond the Pandemic

Telemedicine stands out as a transformative force, offering a lifeline to patients and providers alike. As we move beyond the pandemic, the challenge is to integrate this technology without escalating costs or overshadowing the indispensable role of in-person consultations.

By |November 30, 2024|Categories: Article, Healthcare, Technology|Tags: , |0 Comments